Glaxosmithkline Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Sep '24
Jun '24
Mar '24
Dec '23
Sep '23
Total Qtr Revenue cr
1,045.31
850.29
959.63
833.37
985.20
Other Income Qtr Cr34.5435.6429.8328.1128.21
Operating Revenues Qtr1,010.77814.65929.80805.26956.99

*All values are in Cr.

Operating Expenses Qtr
689.06
584.11
672.54
587.20
667.50
Operating Profit Qtr
321.71
230.54
257.26
218.06
289.49
EBIDT Qtr Cr
360.94
266.18
289.49
82.86
317.70
Depreciation Qtr
16.86
16.41
18.10
17.11
18.11
Net Profit Qtr
252.50
182.33
194.48
45.72
217.51
Basic EPS Qtr
14.91
10.76
11.37
9.89
12.84
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -